Literature DB >> 34245327

Circular RNA circNRIP1 plays oncogenic roles in the progression of osteosarcoma.

Yibin Meng1, DingJun Hao1, YunFei Huang1, ShuaiJun Jia1, JiaNan Zhang1, XiRui He1, Deyin Liu2, Liang Sun3.   

Abstract

Osteosarcoma (OS) is the most common malignant bone tumor in children and adolescents. Increasing evidence suggests that aberrant expression of circRNAs is associated with the occurrence and progression of many cancers. Here, we investigated the role of circNRIP1 in osteosarcoma and explored its possible underlying mechanisms. Three pairs of osteosarcoma tissues and adjacent normal tissues were applied to the detection of altered expression of circRNAs through circRNAs microarray. And the level of circNRIP1 expression was elevated in osteosarcoma tissues. Compared with that in adjacent normal tissue, circNRIP1 expression level was obviously elevated in 100 osteosarcoma tissues. Besides, circNRIP1 knockdown inhibited proliferation and migration, promoted apoptosis of osteosarcoma cells. Bioinformatic analysis demonstrated circNRIP1 contributed to FOXC2 expression by sponging miR-199a. Furthermore, METTL3 elevated circNRIP1 expression level via m6A modification. In short, METTL3-induced circNRIP1 exerted an oncogenic role in osteosarcoma by sponging miR-199a, which may provide new ideas for the treatment of osteosarcoma.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34245327     DOI: 10.1007/s00335-021-09891-3

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


  1 in total

1.  miR-199a-3p negatively regulates the progression of osteosarcoma through targeting AXL.

Authors:  Rui Tian; Xianbiao Xie; Ju Han; Canqiao Luo; Bicheng Yong; Huizhi Peng; Jingnan Shen; Tingsheng Peng
Journal:  Am J Cancer Res       Date:  2014-11-19       Impact factor: 6.166

  1 in total
  4 in total

1.  CircNRIP1 acts as a sponge of miR-1200 to suppress osteosarcoma progression via upregulation of MIA2.

Authors:  Ruoxuan Hei; Jinnan Chen; Xiaojing Zhang; Huiqin Bian; Chen Chen; Xuan Wu; Tiaotiao Han; Yiming Zhang; Junxia Gu; Yaojuan Lu; Qiping Zheng
Journal:  Am J Cancer Res       Date:  2022-06-15       Impact factor: 5.942

2.  METTL3 stabilizes HDAC5 mRNA in an m6A-dependent manner to facilitate malignant proliferation of osteosarcoma cells.

Authors:  Renbing Jiang; Zhibing Dai; Junshen Wu; Suzhi Ji; Yachao Sun; Wenpeng Yang
Journal:  Cell Death Discov       Date:  2022-04-08

Review 3.  miR-199a: A Tumor Suppressor with Noncoding RNA Network and Therapeutic Candidate in Lung Cancer.

Authors:  Wei Meng; Yanli Li; Binshu Chai; Xiaomin Liu; Zhongliang Ma
Journal:  Int J Mol Sci       Date:  2022-07-31       Impact factor: 6.208

Review 4.  Novel insights into the interaction between N6-methyladenosine methylation and noncoding RNAs in musculoskeletal disorders.

Authors:  Juanjuan Han; Hui Kong; Xueqiang Wang; Xin-An Zhang
Journal:  Cell Prolif       Date:  2022-06-23       Impact factor: 8.755

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.